IRADIMED CORPORATION Cash and Cash Equivalents, Period Increase (Decrease)
IRADIMED CORPORATION (IRMD) reported Cash and Cash Equivalents, Period Increase (Decrease) of $492.11 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-08.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-03-08
- IRADIMED CORPORATION cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was -$200.33K, a 111.72% decline year-over-year.
- IRADIMED CORPORATION cash and cash equivalents, period increase (decrease) for the quarter ending 2017-09-30 was $1.61M, a 59.23% decline year-over-year.
- IRADIMED CORPORATION cash and cash equivalents, period increase (decrease) for the quarter ending 2016-12-31 was $1.71M.
- IRADIMED CORPORATION cash and cash equivalents, period increase (decrease) for the quarter ending 2016-09-30 was $3.94M.
- IRADIMED CORPORATION cash and cash equivalents, period increase (decrease) for fiscal 2017 was $492.11K.
- IRADIMED CORPORATION cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$1.65M, a 116.69% decline from fiscal 2015.
- IRADIMED CORPORATION cash and cash equivalents, period increase (decrease) for fiscal 2015 was $9.91M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2017-12-31 | -$200.33K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $1.41M derived: sum of 2 quarters · filed 2018-03-08 | $492.11K 10-K · filed 2018-03-08 | |
| 2017-09-30 | $1.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $692.43K 10-Q · filed 2017-11-06 | ||
| 2017-06-30 | -$913.25K 10-Q · filed 2017-08-04 | |||
| 2016-12-31 | $1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $5.65M derived: sum of 2 quarters · filed 2018-03-08 | -$1.65M 10-K · filed 2018-03-08 | |
| 2016-09-30 | $3.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | -$3.36M 10-Q · filed 2017-11-06 | ||
| 2016-06-30 | -$7.30M 10-Q · filed 2017-08-04 | |||
| 2015-12-31 | $9.91M 10-K · filed 2018-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |